To coincide with the conference, we’ve put together a special release of 5 BioTech Nation interviews…
These are the JP Morgan Conference 2026 BioTech Nation “5”!
We hear from 5 unique BioTech companies ready to make a difference.
Hear their stories directly from the founders, CEOs, and scientists that are making waves in the biotech world:
💡 A New Way to Treat Cancer - Cyriac Roeding & Dr. David Suhy, Earli
💡 A Speedy Intervention for Heart Attacks - Dr. Harry Selker & Atul Deshpande Ph.D., MBA, A-PMP, IMMEDIATE Therapeutics
💡 A Fast-Acting Dupixent? - Dr. Barry Quart, Connect Biopharma
💡 You’ve Had Back Pain for 7-10 Years?- Neil Klompas, Augurex Life Sciences Corp.
💡 A Euphoria-Suppressing Opioid - Ketan Mehta, Tris Pharma
Listen to all 5 interviews here:
Welcome to BioTech Nation !!! With comprehensible interviews, BTN podcasts attract a wide global audience - from bioentrepreneurs interested in the bioentrepreneurship journey, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists seeking insights from the work of others, to everyday people looking for hope from new treatments under development. BioTech Nation is the voice of human endeavor, an endeavor that will benefit many, and sometimes, all. These interviews are drawn directly from the public radio program, "Tech Nation", which can be heard on domestic and global radio, as well as through your favorite podcasting venues.
Recommended Episode
A Fast-Acting Dupixent? Dr. Barry Quart, CEO, Connect Biopharma
On this episode of BioTech Nation, Moira speaks with Dr. Barry Quart, CEO of Connect Biopharma, about a new fast-acting treatment for inflammatory conditions like Asth...
Latest Episodes
When Wounds Won't Heal... Jason Matuszewski, CEO, BioStem Technologies
This week on BioTech Nation, BioSTEM Technologies CEO Jason Matuszewski explains how donated placental tissue is being used to treat chronic wounds that just won’t hea...
Snake Bite Man meets Biotech Scientist creates Breakthrough Antivenom Vaccine … Dr. Jake Glanville, Founder, Chairman & CEO of Centivax
This week on BioTech Nation, Biotech Entrepreneur, Dr. Jake Glanville, Founder, Chair and CEO of Centivax, gives us the insider’s view of this Biotech Breakthrough – f...
What’s Next in Health? Highlights from NextMed 2025... Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
This week on BioTech Nation, Dr. Daniel Kraft, Tech Nation Health Chief Correspondent, returns with highlights from the 2025 NextMed Health conference. From AI-powered...
How Can a Treatment Become a Vaccine??? Dr. Peter DeMuth, Chief Scientific Officer at Elicio Therapeutics
Dr. Peter DeMuth, Chief Scientific Officer of Elicio Therapeutics, discusses the revolutionary approach of detecting cancer at its earliest stages through circulating ...
PART II: A Regenerative Leap for Epilepsy… Dr. Cory Nicholas, Co-Founder and CEO, Neurona Therapeutics
This week on BioTech Nation, Dr. Cory Nicholas, CEO of Neurona Therapeutics, returns for part two. With early results now in from Neurona’s first clinical trial, patie...
